Chemed (CHE) is down -10.1%, or -$56.39 to $502.97.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHE:
- Chemed price target lowered to $640 from $674 at RBC Capital
- Oppenheimer says Chemed should be down significantly on Vitas Florida Cap impact
- Chemed price target lowered to $650 from $708 at BofA
- Chemed’s Resilience Amid Challenges: Justifying a Buy Rating with Strong Long-Term Prospects
- Chemed Lowers Earnings Guidance for 2025